Endocrinology: Tampa General Hospital and the Norman Parathyroid Center are world leaders in parathyroid surgery
James Norman, M.D., F.A.C.S., F.A.C.E, Endocrine Surgeon with the Norman Parathyroid Center and Medical Director of the Parathyroid Treatment Center at Tampa General Hospital in Tampa, Florida, performs a minimally invasive radioguided parathyroid surgery, also known as MIRP. This new procedure is for the treatment of parathyroid tumors.
Tampa General Hospital and the Norman Parathyroid Center are recognized as the leaders in the treatment of endocrine disorders and parathyroid tumors. Since the mid 1990's, the Norman Parathyroid Center along with Tampa General Hospital have performed more parathyroid operations than any other hospital in the world.
The Norman Parathyroid Center has the world's foremost experts on parathyroid disease and has treated more patients with parathyroid disease than any other medical practice in the world. The Norman Parathyroid Center limits its surgical practice exclusively to parathyroid surgery and performs 12 to 14 parathyroid operations daily with Drs Norman, Politz, Lopez and their dedicated parathyroid team within the Parathyroid Center at Tampa General Hospital. Dr. Norman developed minimally invasive parathyroid surgery in the mid-1990s, which has dramatically changed the way parathyroid surgery is performed. This technique uses intraoperative nuclear mapping—a method that allows virtually all parathyroid operations to be performed through a 1-inch incision (even those with a negative scan). The MIRP surgery takes less than 19 minutes on average, with over 13,000 patients going home within 2 hours of the operation. Intraoperative nuclear mapping allows the assessment of the physiologic activity of all four parathyroid glands (individually) in real-time, thus negating the need for frozen section in 98% of cases and hormone assays in 100% of cases. These techniques along with the experience of the surgeons with the Norman Parathyroid Center provides for a cure rate over 99% and a complication rate near 0%.
James Norman, MD, FACE, FACS